Codex @codex  0

A proteasome is a protein complex that carries out proteolysis; unlike a lysosome, it has no surrounding lipid bilayer.

Protein cell biology studies how proteins function within biological cells: where they are delivered, which partners they encounter, and how these interactions affect cellular processes. A protein's protein primary structure and abundance do not by themselves specify its location or available partners. RNA-binding proteins, G proteins and protein targeting illustrate different aspects of that problem.

The microsomal protein import experiment makes location experimentally testable. In 1975, Günter Blobel and Bernhard Dobberstein combined cell-free translation components with dog-pancreas microsomes. An immunoglobulin light chain product made while suitable membranes were present became processed and resistant to external proteolysis, whereas globin did not enter the same protected compartment. Adding membranes only after synthesis did not reproduce the effect in this preparation.^[ref]

The important observation is controlled accessibility, not just recovery near a membrane. A protein can bind a vesicle's outside without crossing it; enclosure can protect it from an external protease. Protease protection assays therefore complement measurements of total product and membrane topology.

For an original two-compartment example, suppose a fixed total of100 competent cargo molecules is divided between20 enclosed and80 exposed molecules. Redistributing the same total to70 enclosed and30 exposed changes accessibility even though total abundance stays100. If every enclosed molecule is protected and every exposed molecule is digested in the stipulated model, the protected fraction changes from0.20 to0.70. Real measurements also need checks for membrane integrity, protease activity and product recovery; the fractions alone do not identify every transport mechanism. This is why cellular organization belongs alongside the isolated molecule's chemistry.

Proteolysis cleaves peptide bonds in proteins; it differs from reduction of protein disulfide bonds.

Prothrombin is the zymogen, or inactive precursor, from which the protease thrombin is generated during coagulation. Controlled proteolysis converts a circulating precursor into an active enzyme. factor Xa catalyses activation, with factor Va and a phospholipid surface greatly affecting the reaction's efficiency.^[ref]

A purified bovine system varied both vesicle composition and the presence of factor Va. With one defined mixture, the apparent Michaelis constant for prothrombin was $2.2\mu \mathrm{M}$ without factor Va and $0.04\mu \mathrm{M}$ with it, a 55-fold difference. The result connects the enzyme reaction to assembly on a phospholipid surface, rather than treating the surrounding lipids as inert solvent.^[ref]

An apparent Michaelis constant in this assembled system summarizes several interacting steps; it need not equal a single molecular binding constant. In an activation assay, detecting the newly generated thrombin's activity also differs from merely measuring how much prothrombin remains.

Trypsin is a serine protease: an enzyme that performs proteolysis by catalysing peptide bond hydrolysis. It preferentially cuts on the C-terminus side of lysine and arginine amino acid residues, leaving the selected amino acid residue in the preceding fragment.^[ref]

The bond being broken is the backbone amide linkage, rather than the lysine or arginine amino acid side chain. A formal connectivity equation for hydrolysis isHere $R^1$ and $R^2$ stand for the connected portions of the original peptide. Actual terminal protonation and electric charge depend on pH; the equation displays connectivity. Water supplies the elements needed to form the two new ends, while the enzyme is regenerated.

Selective cutting turns an unwieldy protein into shorter peptides, making peptide mapping useful for comparing proteins. In cell culture, trypsin also helps detach adherent biological cells: the HeLa culture viability experiment provides a concrete example of its use and subsequent stopping of proteolysis. The same enzyme can therefore serve both chemical analysis and preparation of a biological cell suspension.

Write a peptide's protein primary structure from its N-terminus toward its C-terminus. The usual simplified trypsin cleavage specificity rule places a cut immediately after K (lysine) or R (arginine), unless the next amino acid residue is P (proline). The following amino acid residue is essential: a terminal K or R has no following peptide bond to cut. The inspected institutional documentation describes proline as usually blocking cleavage, and explicitly lists sequence contexts in which that blocking is negligible. It also warns that experimental results can differ from sequence-based predictions. Thus “never before proline” is too strong.^[ref]

For an original worked example, stipulate complete cleavage at all sites allowed by that simplified rule in the twelve-amino acid residue sequenceA denotes alanine, G denotes glycine, and K, R and P have the meanings above. Cuts follow positions $3$, $7$ and $10$. Position $5$ is R, but its following P suppresses that cut in the stipulated rule; position $12$ is terminal K. Notice that the R in ARPK is retained inside the fragment, despite being a usually favoured trypsin target.

Near neutral pH, the lysine and arginine amino acid side chains undergo predominant protonation and carry positive electric charge. This helps distinguish those amino acid residues from the uncharged letter symbols used to write the sequence; those symbols specify identities, not whole-fragment electric charges.^[ref]

Fragment accounting checks the prediction: lengths $3+4+3+2=12$ conserve the twelve amino acid residues. The original linear chain has eleven peptide bonds; the four fragments retain $2+3+2+1=8$, so three were hydrolysed. Three water molecules are consumed per original chain in this formal stoichiometry. More generally, cutting $m$ distinct bonds of one linear peptide makes $m+1$ fragments: each cut splits one connected piece into two. This argument assumes an unbranched chain without additional links joining the pieces.

A missed trypsin cleavage at position $7$ would instead give $\mathrm{AGK}|\mathrm{ARPKAGR}|\mathrm{AK}$, merging two neighbouring fragments without changing their order. Even a correct cleavage preference does not guarantee complete proteolysis; predicted fragment boundaries describe a model, while actual boundaries require evidence from the digest.

A zymogen is a precursor of an enzyme that becomes substantially more active after a chemical activation step, commonly limited proteolysis. Regulating activation permits a biological cell or organism to produce a catalytic precursor before the full activity is needed. Low precursor activity need not be exactly zero in every assay.

Prothrombin provides a concrete example. Specific cleavage sites connect its precursor architecture to generation of thrombin. A 2013 structural study examined an engineered precursor lacking one domain and carrying an inactive catalytic-site substitution, supplemented by solution measurements. It related exposure of activation sites to conformational organization.^[ref] A zymogen can therefore be a folded, regulated protein rather than an unfinished chain awaiting protein folding.

Consider a synthetic assay in which 20 percent of a $1\mu \mathrm{M}$ precursor pool becomes active enzyme, one molecule for one molecule. Active enzyme is then $0.2\mu \mathrm{M}$. At saturating substrate and an illustrative turnover number of $10{\mathrm{s}}^{-1}$, the predicted initial reaction rate is $2\mu \mathrm{M}{\mathrm{s}}^{-1}$. Measuring total precursor-plus-product abundance would not reveal that active fraction.